IV Iron Use in Patients With Higher Serum Ferritin: Case Study on Anemia in Kidney Disease

IV Iron Use in Patients With Higher Serum Ferritin: Case Study on Anemia in Kidney Disease


Identification: nnj_ma08A6
Issue: March-April 2008
Volume: Vol. 35, No. 2

Standard: $30.00

Description

This article is available to members for free.

Goal: To identify anemia management practices for safely and effectively achieving appropriate hemoglobin (Hb) targets, reducing ESA requirements, addressing elevated serum ferritin levels, and overcoming obstacles to effective erythropoiesis.

Objectives:

  1. Evaluate a case study involving an increase in maintenance IV iron to improve Hb levels and overall patient outcomes.
  2. Understand how to interpret updated KDOQI and FDA recommendations that address emerging information about ESAs, Hb targets, IV iron, and patients with elevated serum ferritin levels.
  3. Discuss the relevance of this information for treating patients on hemodialysis who have anemia and recent evidence that IV iron administration is an effective solution for such patients.


Note: The author has disclosed that she is on Watson Pharma's Speaker Bureau.

Note: This article is supported by a financial grant from Watson Pharma, Inc. This article has undergone peer review. The information in this article does not necessarily reflect the opinions of ANNA or the sponsor.

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content